• BriaCell Therapeutics Corp. Announces Share Consolidation firstwordpharma
    December 24, 2019
    The Company currently has 216,589,090 Common Shares outstanding and if completed, the Consolidation would reduce the issued and outstanding Common Shares to approximately 721,924 Common Shares.
PharmaSources Customer Service